Literature DB >> 2863492

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

P Imbach, H P Wagner, W Berchtold, G Gaedicke, A Hirt, P Joller, C Mueller-Eckhardt, B Müller, E Rossi, S Barandun.   

Abstract

In a randomised, multicentre study intravenous IgG was compared with oral corticosteroids in 108 children with untreated acute immune thrombocytopenic purpura. IgG was an efficient treatment with no severe untoward reactions. The effects of corticosteroids and IgG were identical for rapid responders, who accounted for 62% of all patients. In contrast, patients requiring more than initial treatment responded better if randomised to IgG. The serum IgG level increased two-fold after IgG. A significant rise in IgM levels was observed after both IgG and corticosteroids. The platelet-associated IgG index was high in 75% of all patients. No significant differences between the two treatment groups were found, but rapid responders had a smaller mean initial platelet-associated IgG index which returned more rapidly and more permanently to normal than that of slow responders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863492     DOI: 10.1016/s0140-6736(85)90400-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.

Authors:  O B Eden; J S Lilleyman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

Review 2.  Current concepts in the treatment of immune thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 3.  Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.

Authors:  S V Kaveri; G Dietrich; V Hurez; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

4.  Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.

Authors: 
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

6.  Intravenous immunoglobulin in virus associated haemophagocytic syndrome.

Authors:  P Goulder; D Seward; C Hatton
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

7.  Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia.

Authors:  Kazuhiro Tada; Masayuki Ohta; Kunihiro Saga; Hiroomi Takayama; Teijiro Hirashita; Yuichi Endo; Hiroki Uchida; Yukio Iwashita; Masafumi Inomata
Journal:  Surg Today       Date:  2017-07-19       Impact factor: 2.549

Review 8.  Harmful and beneficial antibodies in immune thrombocytopenic purpura.

Authors:  P A Imbach
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 9.  Overview of ITP treatment modalities in children.

Authors:  G R Buchanan
Journal:  Blut       Date:  1989-07

10.  Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin.

Authors:  A A Pall; M Varagunam; D Adu; N Smith; N T Richards; C M Taylor; J Michael
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.